THEMIS MEDICARE LTD. - 530199 - Intimation Under Regulation 30 And 30A Of SEBI (LODR) Regulations, 2015
Please find attached our intimation under Regulation 30 and 30A under SEBI (LODR) Regulations, 201514-08-2023
14-08-2023
THEMIS MEDICARE LTD. - 530199 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper advertisement under Regulation 47 read with Regulation 30 of the SEBI (LODR) Regulations, 2015 - Publication of an extract of unaudited financial results in newspapers for the quarter ended June 30, 2023.11-08-2023
THEMIS MEDICARE LTD. - 530199 - Unaudited Results For The Quarter Ended June 30, 2023 (Standalone And Consolidated)
Please find attached unaudited results for the quarter ended June 30, 2023 (Standalone and Consolidated)10-08-2023
THEMIS MEDICARE LTD. - 530199 - Board Meeting Outcome for Outcome Of Board Meeting Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')
Pursuant to Regulation 30 of the Listing Regulations, this is to inform you that the Board of Directors of the Company, at its meeting held today i.e. on Thursday, August 10, 2023, has inter-alia approved the following: a) The Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2023. A copy of Unaudited Standalone and Consolidated Financial Results for the Quarter ended 30th June, 2023 together with Limited Review Report issued by M/s. Krishaan & Co., Chartered Accountants is enclosed herewith. b) Incorporation of a subsidiary company in India as private limited company. This may be taken as compliance under the Listing Regulations.10-08-2023
THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for Reschedule Of Board Meeting
THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 ,inter alia, to consider and approve This has reference to our letter dated 02nd August, 2023 informing that a meeting of the Board of Directors of Themis Medicare Limited (''the Company'') to be held on Saturday, 12th August, 2023 inter alia, to consider and approve the Un-audited Standalone Financial Results for the Quarter ended on 30th June, 2023. The said meeting is now preponed and rescheduled and will now be held on Thursday, 10th August,2023.03-08-2023
THEMIS MEDICARE LTD. - 530199 - Board Meeting Intimation for To Consider And Approve The Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended On 30Th June, 2023.
THEMIS MEDICARE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 ,inter alia, to consider and approve With respect to the captioned subject, please be informed that a meeting of the Board of Directors of Themis Medicare Limited is scheduled to be held on Saturday, 12th August, 2023 inter alia, to consider and approve the Un-audited Standalone and Consolidated Financial Results for the Quarter ended on 30th June, 2023. Further, in continuation of our Letter dated 27th June, 2023, the Trading Window in respect of dealing in the Company's Securities was closed for all Directors/Designated Employees from the opening of the trading hours on Saturday, 1st July, 2023, which shall remain closed till the closure of trading hours on Monday, 14th August, 2023 (both days inclusive) i.e. till the completion of 48 hours after the declaration of financial results as per the policy for prohibition of Insider Trading ("the Code") adopted by the Company pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 as amended from time to time. This is for your information and record.02-08-2023
THEMIS MEDICARE LTD. - 530199 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We are enclosing herewith a certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended June 30, 2023, as received from M/s. Link Intime India Private Limited, Registrar and Share Transfer Agent of the Company. This is for your information and record.10-07-2023
THEMIS MEDICARE LTD. - 530199 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Pursuant to Regulation 39(3) of the SEBI(LODR) Regulation 2015, we would like to inform that the Registrar and Transfer Agent of the Company i..e. Link Intime India Private Limited has received the below mentioned intimation/request for loss of share Certificate/issuance of duplicate share certificate from the Bipin Thakkar 8190, Distinctive No. 3526801- 3526900 No. of Share 100. We shall issue the duplicate certificate only after necessary formalities are carried out by the shareholder.29-06-2023
THEMIS MEDICARE LTD. - 530199 - Closure of Trading Window
We would like to inform you that as per the Company''s minimum Standards Code of Conduct to regulate, monitor and report trading by its Employees and other Connected Persons under SEBI (Prohibition of Insider Trading) Regulations, 2015 (as amended) (PIT Regulations) and pursuant to BSE Circular Ref No: LIST/COMP /01/2019-20 dated 2nd April, 2019 and NSE Circular Ref No. NSE/CML/2019/11 on the provisions of Clause 4 of the Schedule B of the PIT regulations, the Trading Window for dealing in the Securities of the Company shall remain closed on and from Saturday, 1st July 2023 and will re-open after completion of 48 hours from the declaration of financial results for the quarter ended 30th June, 2023 by the Board of Directors of the Company. Further the date of Board Meeting for considering the said financial results for the quarter ended 30th June, 2023 shall be intimated in due course. This is for your information and record.27-06-2023